Mutation Takes No Vacation: Can Structured Treatment Interruptions Increase the Risk of Drug-Resistant HIV-1?
- 1 December 2000
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 25 (5), 398-402
- https://doi.org/10.1097/00126334-200012150-00003
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppressionAIDS, 2000
- Is interruption of HIV therapy always harmful?Journal of Antimicrobial Chemotherapy, 2000
- T lymphocyte responses in HIV-1 infection: implications for vaccine developmentCurrent Opinion in Immunology, 1999
- Rate of HIV-1 RNA rebound upon stopping antiretroviral therapyAIDS, 1999
- HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatmentAIDS, 1999
- Mathematical Analysis of HIV-1 Dynamics in VivoSIAM Review, 1999
- Mathematical Analysis of Antiretroviral Therapy Aimed at HIV-1 Eradication or Maintenance of Low Viral LoadsJournal of Theoretical Biology, 1998
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996